Alzheimer disease therapy (University of Illinois)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAlzheimer disease therapy (University of Illinois)
Drug Alias NameCLZ-2CLZ-3CLZ-1
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNeuroprotectantsBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Illinois
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A